Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/19/2014US8809300 Depolymerized glycosaminoglycan from Thelenota ananas and preparation method thereof
08/19/2014US8809299 Combination therapy for the treatment of cancer
08/19/2014US8809298 Methods, compositions, unit dosage forms, and kits testing for pharmacologic stress testing with reduced side effects
08/19/2014US8809295 Composition containing inhibitors of the expression or activity of SH3RF2 for preventing or treating cancer
08/19/2014US8809290 Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
08/19/2014US8809289 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer
08/19/2014US8809286 Conjugated antimicrobial agents
08/19/2014US8809285 Monophosphorylated lipid A derivatives
08/19/2014US8809284 Compositions and methods related to calcitriol
08/19/2014US8809283 Proteasome inhibitors and uses thereof
08/19/2014US8809282 Method of reducing titers of antibodies specific for a therapeutic agent
08/19/2014US8809280 Therapeutic peptides
08/19/2014US8809274 Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof
08/19/2014US8809265 Methods for treating HCV
08/19/2014US8809024 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
08/19/2014US8809011 HIFα hydroxylation assay
08/19/2014US8808765 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
08/19/2014US8808764 Methods and compositions for increasing growth hormones
08/19/2014US8808763 Methods for improving sleep efficiency in healthy human beings
08/19/2014US8808755 Hydrogen peroxide-based skin disinfectant
08/19/2014US8808753 Methods for treating pustular psoriasis
08/19/2014US8808751 Methods for the preparation of biologically active compounds in nanoparticulate form
08/19/2014US8808749 Polymer conjugate of bioactive substance having hydroxy group
08/19/2014US8808746 Sustained-release microspheres and methods of making and using same
08/19/2014US8808745 Morphine polymer release system
08/19/2014US8808744 Drug delivery system based on polyethylene vinylacetate copolymers
08/19/2014US8808743 Benzonatate compositions and methods of use
08/19/2014US8808742 Compositions and methods for preparing and using same
08/19/2014US8808741 Tamper resistant dosage forms
08/19/2014US8808740 Encased tamper resistant controlled release dosage forms
08/19/2014US8808739 Orodispersible tablet containing compacted sildenafil base
08/19/2014US8808737 Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
08/19/2014US8808734 Cannabinoid formulations
08/19/2014US8808731 Adhesive pharmaceutical preparation containing bisoprolol
08/19/2014US8808728 Feed additive for laying hen and feed containing the same
08/19/2014US8808716 Topical foam composition
08/19/2014US8808714 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
08/19/2014US8808702 Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
08/19/2014US8808700 Use of TNF alpha inhibitor for treatment of erosive polyarthritis
08/19/2014US8808698 Methods for inhibition of lymphangiogenesis and tumor metastasis
08/19/2014US8808692 Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
08/19/2014US8808680 Ionomeric silicone thermoplastic elastomers
08/19/2014US8808679 Auristatin compounds and conjugates thereof
08/19/2014US8808669 Gastroretentive, extended release composition of therapeutic agent
08/19/2014US8808664 Lipidated glycoprotein particles and methods of use
08/19/2014CA2795275C Lyophilized formulation of pectin-adriamycin conjugate and preparation method thereof
08/19/2014CA2784553C Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof
08/19/2014CA2762878C Crystalline forms of a pharmaceutical compound
08/19/2014CA2760555C Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
08/19/2014CA2724629C Tetrahydrocyclopenta[b]indole androgen receptor modulators
08/19/2014CA2691571C An inhalable composition
08/19/2014CA2675142C Fused aromatic difluoromethanephosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors
08/19/2014CA2654801C Quinolinone derivatives and their pharmaceutical compositions
08/19/2014CA2651285C Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
08/19/2014CA2651022C 12-aryl or heteroaryl prostaglandin analogs
08/19/2014CA2649924C Inhibitors of c-fms kinase
08/19/2014CA2647445C N-hydroxy-3-(4-{3-phenyl-s-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
08/19/2014CA2630704C Pharmaceutical composition
08/19/2014CA2627839C Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
08/19/2014CA2627419C Novel method for preparing quaternary acid and ammonium salts
08/19/2014CA2623462C Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
08/19/2014CA2623350C Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
08/19/2014CA2622608C Dipeptidyl peptidase inhibitors for treating diabetes
08/19/2014CA2612265C 2-substituted benzimidazoles
08/19/2014CA2608367C Compositions and methods for inhibition of the jak pathway
08/19/2014CA2602545C Phenyl-n-acyl derivatives of amines and amino acids, a process for the preparation thereof, a pharmaceutical composition and the use thereof
08/19/2014CA2599349C Hair and/or scalp care compositions incorporating amino-oxo-indole-ylidene compounds
08/19/2014CA2591970C Polyethylene glycolated superoxide dismutase mimetics
08/19/2014CA2574437C Infusion and injection solution of levodopa
08/19/2014CA2565221C Biodegradable intravitreal tyrosine kinase inhibitors implants
08/19/2014CA2562473C Preventive and/or therapeutic agent for inflammatory bowel diseases
08/19/2014CA2545435C Hydroxy piperidine derivatives to treat gaucher disease
08/19/2014CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use
08/19/2014CA2475338C Treatment of ophthalmic disorders using urea and urea derivatives
08/19/2014CA2411596C Therapeutic agents - ii
08/14/2014WO2014124458A1 Compositions and methods for treating neurodegenerative diseases
08/14/2014WO2014124433A1 5'-triphosphate oligoribonucleotides
08/14/2014WO2014124430A1 Nucleotide and nucleoside therapeutic compositions and uses related thereto
08/14/2014WO2014124418A1 Modulators of methyl modifying enzymes, compositions and uses thereof
08/14/2014WO2014124396A1 Therapeutic strategies for the treatment of preeclampsia
08/14/2014WO2014124317A1 Analgesic conjugates
08/14/2014WO2014124302A1 Fluorinated integrin antagonists
08/14/2014WO2014124245A1 Modified glycolipids and methods of making and using the same
08/14/2014WO2014124234A1 Alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/14/2014WO2014124208A1 NSAIDs DERIVATIVES AND USES THEREOF
08/14/2014WO2014124141A1 Metformin derivatives for treating diabetes
08/14/2014WO2014124132A1 Stable pharmaceutical composition of clopidogrel free base for oral and parenteral delivery
08/14/2014WO2014124092A2 Lamivudine salts
08/14/2014WO2014124013A1 Amino diol derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/14/2014WO2014123977A1 Geranylgeranylacetone formulations
08/14/2014WO2014123919A1 Method of treating patients non-responsive to palonosetron
08/14/2014WO2014123909A1 Positive allosteric modulators of the gaba-a receptor in the treatment of autism
08/14/2014WO2014123900A1 Anti-cancer and anti-hiv compounds
08/14/2014WO2014123899A1 Tamper resistant pharmaceutical formulations
08/14/2014WO2014123894A1 Macrocyclic compounds as hcv entry inhibitors
08/14/2014WO2014123892A1 Macrocyclic molecules as hcv entry inhibitors
08/14/2014WO2014123889A1 C-19 modified triterpenoids with hiv maturation inhibitory activity
08/14/2014WO2014123882A1 2,6,7 substituted purines as hdm2 inhibitors
08/14/2014WO2014123880A1 Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
08/14/2014WO2014123794A1 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 7860